-- Days : -- HRS : -- MIN : -- SEC
Register Now →

Patricia Novo, MPA, MPH

Articles by Patricia Novo, MPA, MPH

The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).